Stimcell Energetics (STME) Cash from Investing Activities (2016 - 2020)
Stimcell Energetics' (STME) quarterly Cash from Investing Activities came in at -$1574.0 in Q3 2020, up 36.09% year-on-year from -$1156.6 in Q3 2019, and up 36.09% quarter-over-quarter from -$2463.0 in Q3 2019.
Stimcell Energetics (STME) Cash from Investing Activities (2016 - 2020) Analysis & Trends
Stimcell Energetics' Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$1574.0 for Q3 2020.
- On a quarterly basis, Cash from Investing Activities rose 36.09% year-over-year to -$1574.0 in Q3 2020; TTM through May 2021 was -$1574.0, a 36.09% increase from a year earlier, with the FY2021 full-year figure at -$1574.0, up 36.09% from the prior year.
- Cash from Investing Activities rose to -$1574.0 in Q3 2020 per STME's latest filing, from -$2463.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$1574.0 in Q3 2020 and bottomed at -$185242.0 in Q2 2016.
- The 5-year median for Cash from Investing Activities is -$8701.5 (2016), against an average of -$50238.0.
- Biggest YoY gain for Cash from Investing Activities was 36.09% in 2020; the steepest drop was 36.09% in 2020.
- Year by year, Cash from Investing Activities stood at -$14940.0 in 2016, then tumbled by 537.84% to -$95294.0 in 2017, then surged by 97.99% to -$1915.0 in 2018, then dropped by 28.62% to -$2463.0 in 2019, then soared by 36.09% to -$1574.0 in 2020.
- Per Business Quant, the three latest STME Cash from Investing Activities figures stand at -$1574.0 (Q3 2020), -$2463.0 (Q3 2019), and -$1915.0 (Q4 2018).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2020 | -1,574.00 |
| Aug 31, 2020 | -1,574.00 |
| Aug 31, 2019 | -2,463.00 |
| Aug 31, 2019 | -2,463.00 |
| Nov 30, 2018 | -1,915.00 |
| Nov 30, 2018 | -1,915.00 |
| Feb 28, 2017 | -95,294.00 |
| Feb 28, 2017 | -95,294.00 |
| Aug 31, 2016 | -14,940.00 |
| Aug 31, 2016 | -14,940.00 |
| May 31, 2016 | -185,242.00 |
| May 31, 2016 | -185,242.00 |